NCT06781593 Combining Light Therapy and CPAP in Depression
| NCT ID | NCT06781593 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hôpital le Vinatier |
| Condition | Major Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2025-01-17 |
| Primary Completion | 2027-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2025-01-17 with a primary completion date of 2027-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In a double-blind, parallel-group controlled trial, we aim to measure the effect of two weeks of light therapy combined with the CPAP on compliance CPAP in patients with major depressive disorder.
Eligibility Criteria
Inclusion Criteria: * Adults consulting at the MICHEL JOUVET unit, CH Le Vinatier, Bron * Adults with a diagnosis of major depressive episode (DSM-V) and with a MADRS score ≥ 15 * Adults with a diagnosis of OSAS on ventilatory polygraphy or polysomnography (AASM 2017 criteria) requiring CPAP. Exclusion Criteria: * Refusal to participate. * Pregnant and breast-feeding women * Under guardianship or curatorship. * Unstable psychiatric or physical pathology (e.g., hypomania, high suicidal risk) considered incompatible with the study by the investigators. * Other psychiatric, neurologic or somatic conditions * Contraindication to light therapy: retinopathy, retinitis pigmentosa, diabetic retinopathy, macular degeneration, glaucoma, recent eye surgery (less than 3 months). patient wishing to choose a provider other than the protocol provider. * Patient wishing to choose a device other than SEFAM's S-BOX or a mask other than the nasal mask at the time of introduction. * Nasal obstruction. * Refusal to use actimetry, refusal to use light therapy, refusal to use CPAP.
Contact & Investigator
Sébastien S CATOIRE, DR
PRINCIPAL INVESTIGATOR
Centre Hospitalier le Vinatier
Frequently Asked Questions
Who can join the NCT06781593 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Major Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06781593 currently recruiting?
Yes, NCT06781593 is actively recruiting participants. Contact the research team at sebastien.catoire@ch-le-vinatier.fr for enrollment information.
Where is the NCT06781593 trial being conducted?
This trial is being conducted at Bron, France, Bron, France.
Who is sponsoring the NCT06781593 clinical trial?
NCT06781593 is sponsored by Hôpital le Vinatier. The principal investigator is Sébastien S CATOIRE, DR at Centre Hospitalier le Vinatier. The trial plans to enroll 130 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.